In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

Lung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...

Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have ...

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...

Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

November is Lung Cancer Awareness Month, and early detection is in the air. According to the Centers for Disease Control, ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

Content by Intermountain Health Regional Communications. Did you know that raising awareness and encouraging screening can ...

One in 16 Americans will be diagnosed with lung cancer in their lifetime. As the leading cause of cancer deaths in the U.S., ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Mercy Health – Springfield is working to increase early diagnosis of and access to treatment for lung cancer. Lung and ...